Company news
Jiangsu Cowin Biotech Co., Ltd. Class A (SSE:688426) news
Jiangsu Cowin Biotech Co., Ltd. Class A news releases on 6ix. Latest, Nov 19, 2024: Announcement on Resignation of Director
Press releases — page 2
Announcement on Resignation of Director
November 18, 2024
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2024
November 15, 2024
Announcement on Opening Special Account for Raised Funds and Signing Four-party Supervision Agreement for Raised Funds by New Entity of Investment Projects Financed by Raised Funds
October 31, 2024
Announcement on Convening the Q3 2024 Performance Briefing
October 29, 2024
Announcement on Voluntary Disclosure of Obtaining Class III Medical Device Registration Certificate for Novel Coronavirus Nucleic Acid Detection Kit
October 25, 2024
Announcement on Listing and Circulation of Partial Restricted Stocks for Strategic Placement in Initial Public Offering
October 16, 2024
Announcement on the Expiration of Share Reduction Plan for Shareholders and Result of Shareholding Reduction
September 30, 2024